Position in BMY
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$29,313,598
+$21,111,596 QoQ
Shares Held
508,740
+276.2% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#227
of 2,506 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Derivatives in BMY
reported options exposure · as of Dec 31, 2025CallValue
$0
CallShares
0
PutValue
$2,697,000
PutShares
50,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Jefferies Financial Group Inc. holds $358,862,750 across 12 Drug Manufacturers - General names. BMY ranks #6 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
239,779 | $86,828,771 | |
| 2 | ABBV |
AbbVie Inc.
|
268,264 | $67,505,952 | |
| 3 | MRK |
Merck & Co., Inc.
|
362,956 | $46,639,846 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
345,805 | $43,689,003 | |
| 5 | AZN |
Astrazeneca PLC
|
186,676 | $35,397,503 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
508,740 | $29,313,598 | |
| 7 | JNJ |
Johnson & Johnson
|
68,010 | $17,272,499 | |
| 8 | PFE |
Pfizer Inc
|
642,123 | $15,462,321 |
All Filings in BMY
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,313,598 | 508,740 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $8,202,002 | 135,235 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $2,697,000 | 50,000 | Put | Defined | 2026-02-09 | |
| 2025-12-31 | $27,281,395 | 505,773 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $5,594,609 | 124,049 | Shares | Defined | 2025-11-13 | |
| 2025-09-30 | $2,877,380 | 63,800 | Put | Defined | 2025-11-13 | |
| 2025-06-30 | $3,352,923 | 72,433 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $3,058,709 | 50,151 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $13,971,903 | 247,028 | Shares | Defined | 2025-02-27 | |
| 2024-09-30 | $14,415,902 | 278,622 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $9,595,672 | 231,054 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $6,456,732 | 119,062 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $389,956 | 7,600 | Call | Defined | 2024-05-06 | |
| 2023-12-31 | $10,038,237 | 195,639 | Shares | Defined | 2024-05-06 | |
| 2023-09-30 | $7,540,324 | 129,916 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,783,757 | 27,893 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,455,510 | 21,000 | Call | Defined | 2023-05-15 | |
| 2023-03-31 | $1,455,510 | 21,000 | Put | Defined | 2023-05-15 | |
| 2023-03-31 | $12,613,934 | 181,993 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,245,050 | 59,000 | Shares | Defined | 2023-09-21 | |
| No filing history on record for this holder in this stock. | ||||||